Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012:5:483-8.
doi: 10.2147/IJGM.S32758. Epub 2012 May 31.

Use of a semiquantitative procalcitonin kit for evaluating severity and predicting mortality in patients with sepsis

Tsuneaki Kenzaka  1 , Masanobu Okayama, Shigehiro Kuroki, Miho Fukui, Shinsuke Yahata, Hiroki Hayashi, Akihito Kitao, Eiji Kajii, Masayoshi Hashimoto
Affiliations

Use of a semiquantitative procalcitonin kit for evaluating severity and predicting mortality in patients with sepsis

Tsuneaki Kenzaka et al. Int J Gen Med. 2012.

Abstract

Background: The aim of this study was to evaluate the clinical usefulness of a semiquantitative procalcitonin kit for assessing severity of sepsis and early determination of mortality in affected patients.

Methods: This was a prospective, observational study including 206 septic patients enrolled between June 2008 and August 2009. Disseminated intravascular coagulation (DIC), Sequential Organ Failure Assessment (SOFA), Acute Physiology and Chronic Health Evaluation (APACHE) II scores were measured, along with semiquantitative procalcitonin concentrations. Patients were divided into three groups based on their semiquantitative procalcitonin concentrations (group A, <2 ng/mL; group B ≥ 2 ng/mL < 10 ng/mL; group C ≥ 10 ng/mL).

Results: A significant difference in DIC, SOFA, and APACHE II scores was found between group A and group C and between group B and group C (P < 0.01). Patients with severe sepsis and septic shock had significantly higher procalcitonin concentrations than did patients with less severe disease. The rate of patients with septic shock with high procalcitonin concentrations showed an upward trend. There was a significant (P < 0.01) difference between the three groups with regard to numbers of patients and rates of severe sepsis, septic shock, DIC, and mortality.

Conclusion: Semiquantitative procalcitonin concentration testing can be helpful for early assessment of disease severity in patients with sepsis. Furthermore, it may also help in predicting early mortality in septic patients. Based on the level of semiquantitative procalcitonin measured in patients with suspected sepsis, a timely decision can be reliably made to transfer them to a tertiary hospital with an intensive care unit for optimal care.

Keywords: Acute Physiology and Chronic Health Evaluation II; Sequential Organ Failure Assessment; mortality; procalcitonin; semiquantitative procalcitonin; sepsis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Comparison of semiquantitative procalcitonin concentrations with rates of severe sepsis and septic shock.
Figure 2
Figure 2
Comparison of semiquantitative procalcitonin concentrations with rate of disseminated intravascular coagulation and mortality. Abbreviations: DIC, disseminated intravascular coagulation.
See this image and copyright information in PMC

References

    1. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock. Crit Care Med. 2008;36:296–327. - PubMed
    1. Tang BM, Eslick GD, Craig JC, McLean AS. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis. 2007;7:210–217. - PubMed
    1. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992;20:864–874. [No authors listed] - PubMed
    1. Aikawa N, Fujishima S, Endo S, et al. Multicenter prospective study of procalcitonin as indicator of sepsis. J Infect Chemother. 2005;11:152–159. - PubMed
    1. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet. 1993;341:515–518. - PMC - PubMed